These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21368605)

  • 21. Procedure guideline for bone pain treatment: 1.0. Society of Nuclear Medicine.
    Silberstein E; Taylor A
    J Nucl Med; 1996 May; 37(5):881-4. PubMed ID: 8965169
    [No Abstract]   [Full Text] [Related]  

  • 22. [Transfering into accessory nasal sinuses and bone in a primary hepatocellular carcinoma patient].
    Chen YX; He ZM; Chang YZ; Qin SK
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):420. PubMed ID: 12890347
    [No Abstract]   [Full Text] [Related]  

  • 23. The treatment of painful osteoblastic metastases: what can we expect from nuclear oncology?
    Silberstein EB
    J Nucl Med; 1994 Dec; 35(12):1994-5. PubMed ID: 7527457
    [No Abstract]   [Full Text] [Related]  

  • 24. Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial.
    Porter AT; McEwan AJ
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):38-43. PubMed ID: 7684865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radionuclide-targeted therapy for the management of metastatic bone pain.
    Ackery D; Yardley J
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):27-31. PubMed ID: 7684862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strontium 89: cost-effective or cost-expensive?
    West P
    Can Oncol Nurs J; 2003; 13(3):191-2. PubMed ID: 14508909
    [No Abstract]   [Full Text] [Related]  

  • 27. [On revision of the manual for the appropriate use of strontium-89 chloride to ease pain associated with bone metastasis].
    Yamashita T
    Kaku Igaku; 2013 Nov; 50(4):297-300. PubMed ID: 24505825
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple skeletal metastases as unusual manifestations of hepatocellular carcinoma in a noncirrhotic liver.
    Shakya VC; Agrawal CS; Pandey SR; Rauniyar RK; Dhungel K; Adhikary S
    Nepal Med Coll J; 2010 Sep; 12(3):198-200. PubMed ID: 21446373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma metastatic to bones (Case report with review of literature).
    Doval DC; Rao CR; Acharya R; Reddy BK; Bapsy PP
    Indian J Cancer; 1995 Mar; 32(1):31-5. PubMed ID: 7558110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
    Papatheofanis FJ
    J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiotherapy of bone metastases. A review of the literature].
    Simon JM
    Bull Cancer Radiother; 1996; 83(4):290-8. PubMed ID: 9081330
    [No Abstract]   [Full Text] [Related]  

  • 32. Question of the month--January 1995. What is the optimal dose of 89Sr for bone pain palliation?
    Khader Z
    Nucl Med Commun; 1995 Apr; 16(4):306. PubMed ID: 7542759
    [No Abstract]   [Full Text] [Related]  

  • 33. Disseminated intravascular coagulation in metastatic prostate cancer.
    Riddell AJ
    J Nucl Med; 1996 Feb; 37(2):401. PubMed ID: 8667086
    [No Abstract]   [Full Text] [Related]  

  • 34. Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron).
    Kan MK
    Cancer Nurs; 1995 Aug; 18(4):286-91. PubMed ID: 7545083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain palliation with strontium-89 in children with metastatic disease.
    Charron M; Brown M; Rowland P; Mirro J
    Med Pediatr Oncol; 1996 Jun; 26(6):393-6. PubMed ID: 8614375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A bone metastasis of hepatocellular carcinoma].
    Nishimori T; Sakazaki S; Park I; Kawaguchi M; Nishigami T
    Gan No Rinsho; 1990 Jul; 36(8):919-23. PubMed ID: 1694902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theoretical data of external Bremsstrahlung radiation cross-section of bone.
    Manjunatha HC; Rudraswamy B
    Appl Radiat Isot; 2007 Apr; 65(4):397-400. PubMed ID: 17113303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disseminated intravascular coagulation in a patient with metastatic prostate cancer: fatal outcome following strontium-89 therapy.
    Leong C; McKenzie MR; Coupland DB; Gascoyne RD
    J Nucl Med; 1994 Oct; 35(10):1662-4. PubMed ID: 7931669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nuclear medicine therapy of bone metastases].
    Kimmig B; Hermann HJ; Kober B
    Rontgenblatter; 1983 Jul; 36(7):216-9. PubMed ID: 6622951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating symptomatic osseous metastases from prostate cancer.
    Soffen EM; Greenberg AS; Baumann JC
    N J Med; 1997 Nov; 94(11):33-7. PubMed ID: 9385818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.